University Hospital advances cardiology services by offering first-of-its-kind fully dissolving heart stent

Aug. 9, 2016 (AUGUSTA, GA) – The interventional cardiology team at University Hospital’s Heart & Vascular Institute recently became the first in the CSRA and only the second hospital in Georgia to offer patients with coronary artery disease a new treatment option that literally disappears over time.

University Hospital’s first use of the world's first FDA-approved dissolving heart stent occurred Monday, August 08, 2016. In two separate cases, the Absorb stent was used by interventional cardiologists Patrick Hall, M.D., and G. Leslie Walters, M.D. The Absorb bioresorbable vascular scaffold is a major advance in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide despite decades of therapeutic advances.

While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in about three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants.

“The development of a dissolving stent is a huge step forward, both for the treatment of coronary artery disease as well as benefit to patients,” Dr. Hall explained. “University Hospital is excited to be able to offer this option to our heart patients.”

To ensure optimal patient selection and implant technique, University Hospital’s interventional cardiology team underwent extensive training on the new device,

More information about the Absorb dissolving heart stent is available online at